Novel bioactive from Lactobacillus brevis DSM17250 to stimulate the growth of Staphylococcus epidermidis: A pilot study

Beneficial Microbes

Volumn 8, Issue 1, 2017, Pages 121-131

  Holz, C ^a   Benning, J ^a   Schaudt, M ^b,c   Heilmann, A ^a   Schultchen, J ^a   Goelling, D ^a   Lang, C ^a  

^a Organobalance GmbH   (Germany)

^b Analyze and Realize GmbH   (Germany)

^c PRA HEALTH SCIENCES   (United States)

Author keywords

Anti inflammatory; Cell free extract; Dry skin; Skin barrier; Staphylococcus epidermidis

Indexed keywords

DERMATOLOGICAL AGENT; INTERLEUKIN 1ALPHA; LACTOBACILLUS BREVIS EXTRACT; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; OINTMENT; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY SKIN AREA AND SEVERITY INDEX; FEMALE; GERMANY; GROWTH STIMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LACTOBACILLUS BREVIS; MALE; NONHUMAN; PATIENT COMPLIANCE; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SKIN DISEASE; SKIN DISEASE ASSESSMENT; SKIN FLORA; SKIN WATER LOSS; STAPHYLOCOCCUS EPIDERMIDIS; STINGING; TREATMENT DURATION; XERODERMA; XEROSIS CUTIS; ADMINISTRATION AND DOSAGE; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; OINTMENT; SKIN; SKIN DISEASES; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS BREVIS; MALE; MICROBIOTA; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; PLACEBOS; SKIN; SKIN DISEASES; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME;

EID: 85013178233     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2016.0073     Document Type: Article

References (40)

1. Al-Ghazzewi, F. H. and Tester, R. F., 2010. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. International Journal of Cosmetic Science 32: 139-142
2. Baird-Parker, A. C., 1963. A classification of micrococci and staphylococci based on physiological and biochemical tests. Journal of General Microbiology 30: 409-427
3. Baviera, G., Leoni, M. C., Capra, L., Cipriani, F., Longo, G., Maiello, N., Ricci, G. and Galli, E., 2014. Microbiota in healthy skin and in atopic eczema. BioMed Research International 2014: 436921
4. Belkaid, Y. and Segre, J. A., 2014. Dialogue between skin microbiota and immunity. Science 346: 954-959
5. Bierbaum, G., Gotz, F., Peschel, A., Kupke, T., van de Kamp, M. and Sahl, H. G., 1996. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Van Leeuwenhoek 69: 119-127
6. Bryld, L. E., Agner, T., Kyvik, K. O., Brondsted, L., Hindsberger, C. and Menne, T., 2000. Hand eczema in twins: a questionnaire investigation. British Journal of Dermatology 142: 298-305
7. Cogen, A. L., Yamasaki, K., Muto, J., Sanchez, K. M., Crotty Alexander, L., Tanios, J., Lai, Y., Kim, J. E., Nizet, V. and Gallo, R. L., 2010. Staphylococcus epidermidis antimicrobial delta-toxin (phenolsoluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PloS One 5: e8557
8. Foster, T. J., 2005. Immune evasion by staphylococci. Nature Reviews Microbiology 3: 948-958
9. Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378
10. Gallo, R. L. and Nakatsuji, T., 2011. Microbial symbiosis with the innate immune defense system of the skin. Journal of Investigative Dermatology 131: 1974-1980
11. Grice, E. A., Kong, H. H., Renaud, G., Young, A. C., Program, N. C. S., Bouffard, G. G., Blakesley, R. W., Wolfsberg, T. G., Turner, M. L. and Segre, J. A., 2008. A diversity profile of the human skin microbiota. Genome Research 18: 1043-1050
12. Gueniche, A., Bastien, P., Ovigne, J. M., Kermici, M., Courchay, G., Chevalier, V., Breton, L. and Castiel-Higounenc, I., 2010. Bifidobacterium longum lysate, a new ingredient for reactive skin. Experimental Dermatology 19: e1-8
13. Gueniche, A., Philippe, D., Bastien, P., Blum, S., Buyukpamukcu, E. and Castiel-Higounenc, I., 2009. Probiotics for photoprotection. Dermato-Endocrinology 1: 275-279
14. Hashizume, H., 2004. Skin aging and dry skin. Journal of Dermatology 31: 603-609
15. Holmes, C. J., Plichta, J. K., Gamelli, R. L. and Radek, K. A., 2015. Dynamic Role of host stress responses in modulating the cutaneous microbiome: implications for wound healing and infection. Advances in Wound Care 4: 24-37
16. Huang, M.-C. J. and Tang, J., 2015. Probiotics in personal care products. Microbiology Discovery 3: 5
17. Imokawa, G. and Ishida, K., 2014. Role of ceramide in the barrier function of the stratum corneum: implications for the pathogenesis of atopic dermatitis. Journal of Clinical & Experimental Dermatology Research 5: 206
18. Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T. and Mizunoe, Y., 2010. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465: 346-349
19. Kleerebezem, M., Quadri, L. E., Kuipers, O. P. and De Vos, W. M., 1997. Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Molecular Microbiology 24: 895-904
20. Lai, Y., Cogen, A. L., Radek, K. A., Park, H. J., Macleod, D. T., Leichtle, A., Ryan, A. F., Di Nardo, A. and Gallo, R. L., 2010. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. Journal of Investigative Dermatology 130: 2211-2221
21. Larson, E. L., Hughes, C. A., Pyrek, J. D., Sparks, S. M., Cagatay, E. U. and Bartkus, J. M., 1998. Changes in bacterial flora associated with skin damage on hands of health care personnel. American Journal of Infection Control 26: 513-521
22. Lavigne, J. P., Sotto, A., Dunyach-Remy, C. and Lipsky, B. A., 2015. New molecular techniques to study the skin microbiota of diabetic foot ulcers. Advances in Wound Care 4: 38-49
23. Lerbaek, A., Kyvik, K. O., Mortensen, J., Bryld, L. E., Menne, T. and Agner, T., 2007a. Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. Journal of Investigative Dermatology 127: 1632-1640
24. Lerbaek, A., Kyvik, K. O., Ravn, H., Menne, T. and Agner, T., 2007b. Incidence of hand eczema in a population-based twin cohort: genetic and environmental risk factors. British Journal of Dermatology 157: 552-557
25. March, J. C. and Bentley, W. E., 2004. Quorum sensing and bacterial cross-talk in biotechnology. Current Opinion in Biotechnology 15: 495-502
26. Nodake, Y., Matsumoto, S., Miura, R., Honda, H., Ishibashi, G., Matsumoto, S., Dekio, I. and Sakakibara, R., 2015. Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe-A blinded randomized clinical trial. Journal of Dermatological Science 79: 119-126
27. Otto, M., 2009. Staphylococcus epidermidis-the 'accidental' pathogen. Nature Reviews Microbiology 7: 555-567
28. Otto, M., 2010. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Reviews in Dermatology 5: 183-195
29. Otto, M., Echner, H., Voelter, W. and Gotz, F., 2001. Pheromone crossinhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infection and Immunity 69: 1957-1960
30. Otto, M., Sussmuth, R., Vuong, C., Jung, G. and Gotz, F., 1999. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Letters 450: 257-262
31. Pag, U., Heidrich, C., Bierbaum, G. and Sahl, H. G., 1999. Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Applied and Environmental Microbiology 65: 591-598
32. Pinnagoda, J., Tupker, R. A., Agner, T. and Serup, J., 1990. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 22: 164-178
33. Rosenthal, M., Goldberg, D., Aiello, A., Larson, E. and Foxman, B., 2011. Skin microbiota: microbial community structure and its potential association with health and disease. Infection Genetics and Evolution 11: 839-848
34. Sanford, J. A. and Gallo, R. L., 2013. Functions of the skin microbiota in health and disease. Seminars in Immunology 25: 370-377
35. Serup, J., 1995. TEWL measurement standardization. Acta Dermato-Venereologica 75: 91-92
36. Stevens, N. T., Sadovskaya, I., Jabbouri, S., Sattar, T., O'Gara, J. P., Humphreys, H. and Greene, C. M., 2009. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cellular Microbiology 11: 421-432
37. Sugimoto, S., Iwamoto, T., Takada, K., Okuda, K., Tajima, A., Iwase, T. and Mizunoe, Y., 2013. Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. Journal of Bacteriology 195: 1645-1655
38. Thomsen, S. F., Ulrik, C. S., Kyvik, K. O., Hjelmborg, J., Skadhauge, L. R., Steffensen, I. and Backer, V., 2007. Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy and Asthma Proceedings 28: 535-539
39. Volz, T. and Biedermann, T., 2009. Inside-Out. Probiotika und atopische Dermatitis [Outside-in. Probiotic topical agents]. Der Hautarzt 60: 795-801
40. World health Organization (WHO). WHO Guidelines on hand hygiene in health care: first global patient safety challenge clean care is safer care. WHO, Geneva, Switzerland. Available at: http://tinyurl. com/o7eqery.